欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1839/001
药品名称Elvanse
活性成分
    • lisdexamfetamine dimesylate 30.0 mg
剂型Capsule, hard
上市许可持有人Shire Pharmaceuticals Ireland Limited Ireland
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 08081/0050 - 0031
    • Germany (DE)
      Elvanse 30 mg Hartkapseln
    • Denmark (DK)
    • Ireland (IE)
    • Spain (ES)
    • Norway (NO)
    • Finland (FI)
    • Austria (AT)
    • Portugal (PT)
    • Poland (PL)
      Elvanse
    • Estonia (EE)
    • Belgium (BE)
      Elvanse 30 mg gélules
    • Netherlands (NL)
    • Luxembourg (LU)
许可日期2012/12/18
最近更新日期2024/11/22
药物ATC编码
    • N06BA12 lisdexamfetamine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase